Deterministic Protein, Peptide, and Enzyme Design and Analysis Platform
Business Model: SAAS B2C
Revenue: $0
Employees: 1-10
Address:
City: Wilmington
State: Delaware
Zip:
Country: United States
Galaxy Genomics Corp. is an American biotechnology company focused on providing the most advanced and specialized software to help companies from different sectors to develop a better future. The Origins SaaS (Software-as-a-Service) Platform uses advanced mathematical and computational algorithms to deliver value to our users. It allows them to create proteins, peptides, and enzymes accurately, achieve significant reductions in research cost and time and develop superior and innovative products.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|